Research Early Stage Global Investors2018-06-05T13:52:48+00:00

Researching Early Stage Global Investors

This workshop provides the basics to create a global target list by doing research on your own. It discusses the best practices to increase precision and efficiency when identifying active investors based on fit for your opportunity. It also introduces fundraising executives to the 10 different investor types as well as provides tactical advice on how to identify the appropriate contact person and what to send in your initial outreach.


Lucy Parkinson, VP of Investor Research, Life Science Nation

Lucy Parkinson is LSN’s VP of Investor Research and leads LSN’s investor outreach and analysis team. She additionally contributes to LSN’s web marketing as the voice of LSN’s videos and a contributing writer on both The Life Science Executive’s Fundraising Manifesto and the Next Phase newsletter. Prior to joining LSN, Lucy spent several years working at CPA fi­rms, gaining experience working with small corporations, partnerships and nonprofi­t organizations. Lucy graduated from the University of Leeds with a degree in the History and Philosophy of Science. She is also a FINRA-registered securities principal and an Enrolled Agent.

James Huang, Research Analyst, Life Science Nation

James Huang is a Research Analyst for LSN in Boston, Massachusetts. Previously, James served as a Research Assistant in the Hematology Division at Washington University in St. Louis, growing modified TFPI and developing assays to detect the efficiency of these mutations. Previously, he served as an analyst at Informulary, a start-up dedicated to analyzing FDA clinical trial data and systematic review data to extract relevant data for use in more easily understood drug labels and for use in advising self-insured employers determine medications to be covered in their formularies. Currently, as a Research Analyst at Life Science Nation (LSN), he collaborates with investors in various life science sectors such as therapeutics, medical devices, diagnostics, and healthcare IT. James also works closely with many Chinese investors and has written articles on the Chinese market based on conversations with these investors and research he has done on the topic. James received his B.A. in Neuroscience from Dartmouth College.

Back to Day 3 Agenda